Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06371105
Other study ID # 014_2018
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 2, 2019
Est. completion date March 30, 2019

Study information

Verified date April 2024
Source University of Taipei
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to assess the effects of 10-week water-based aerobic training (thrice a week) on anthropometrics, biochemicals, cardiovascular parameters, and explosive strength in young overweight and obese women. The findings indicate that water-based aerobic training could be a useful program to enhance body composition, biochemical, cardiovascular, and explosive strength parameters in young overweight and obese women compared to inactive persons


Description:

This study is based on a randomized controlled trial with a pre-to-post testing design, twenty-seven young overweight and obese women were assigned to training group (a water-based aerobic training) or control group (maintaining their usual activities during the studying period. For each training session, water activities were implemented for 50 min which included warm-up (10 min), main activities (30 min), and cool-down (10 min). The swimming pool where the intervention took part was 1.50 m deep of water. The pre- and post-intervention participants were assessed for their anthropometrics, biochemicals (fasting glycemia, total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol and triglyceride (TG)), resting blood pressure, and resting heart rate, and explosive strength of upper (countermovement jump and squat jump) and lower limbs (a seated medicine ball throw test).


Recruitment information / eligibility

Status Completed
Enrollment 31
Est. completion date March 30, 2019
Est. primary completion date March 30, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 29 Years to 35 Years
Eligibility Inclusion Criteria: - Age between 20 and 35 years - Sedentary lifestyle within six month - Not using drugs or other therapy for obesity. Exclusion Criteria: - BMI below 25.0 and over 34.9 kg.m-2 - having any infectious or skin diseases

Study Design


Related Conditions & MeSH terms


Intervention

Other:
10-week water-based aerobic training
The water-based aerobic program was adopted from the protocol previously used by Costa et al. (2018, 2020). This training program was carried out thrice a week over 2 non-consecutive days 48 hours apart for 10 weeks according to ACSM guidelines

Locations

Country Name City State
Taiwan Department of Exercise and Health Sciences, University of Taipei Taipei

Sponsors (1)

Lead Sponsor Collaborator
University of Taipei

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary fasting glycemia in millimoles per liter baseline blood sample 3 days before the 10-week interventional period
Primary total cholesterol in millimoles per liter baseline blood sample 3 days before the 10-week interventional period
Primary high-density lipoprotein cholesterol in millimoles per liter baseline blood samplelipoprotein cholesterol, and triglyceride concentrations 3 days before the 10-week interventional period
Primary low-density lipoprotein cholesterol in millimoles per liter baseline blood sample 3 days before the 10-week interventional period
Primary triglyceride concentrations in millimoles per liter baseline blood sample 3 days before the 10-week interventional period
Primary systolic blood pressure in millimeters of mercury baseline blood sample 3 days before the 10-week interventional period
Primary diastolic blood pressure in millimeters of mercury baseline blood sample 3 days before the 10-week interventional period
Primary heart rate in beat per minute baseline blood sample 3 days before the 10-week interventional period
Primary fasting glycemia in millimoles per liter post-training blood sample one day after the 10-week interventional period
Primary total cholesterol in millimoles per liter post-training blood sample one day after the 10-week interventional period
Primary high-density lipoprotein cholesterol in millimoles per liter post-training blood sample one day after the 10-week interventional period
Primary low-density lipoprotein cholesterol in millimoles per liter post-training blood sample one day after the 10-week interventional period
Primary triglyceride concentrations in millimoles per liter post-training blood sample one day after the 10-week interventional period
Primary systolic blood pressure in millimeters of mercury post-training blood sample one day after the 10-week interventional period
Primary diastolic blood pressure in millimeters of mercury post-training blood sample one day after the 10-week interventional period
Primary heart rate in beat per minute post-training blood sample one day after the 10-week interventional period
Secondary countermovement jump in centimetres baseline lower limbs power test 3 days before the 10-week interventional period
Secondary squat jump in centimeters baseline lower limbs power test 3 days before the 10-week interventional period
Secondary chest 3-kg medicine ball throw in meters baseline upper limbs power test 3 days before the 10-week interventional period
Secondary countermovement jump in centimetres post-training lower limbs power test one day after the 10-week interventional period
Secondary squat jump in centimeters post-training lower limbs power test one day after the 10-week interventional period
Secondary chest 3-kg medicine ball throw in meters post-training upper limbs power test one day after the 10-week interventional period
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2